Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach

MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular electrophysiology 2011-01, Vol.22 (1), p.16-22
Hauptverfasser: AKOUM, NAZEM, DACCARETT, MARCOS, MCGANN, CHRIS, SEGERSON, NATHAN, VERGARA, GASTON, KUPPAHALLY, SUMAN, BADGER, TROY, BURGON, NATHAN, HASLAM, THOMAS, KHOLMOVSKI, EUGENE, MACLEOD, ROB, MARROUCHE, NASSIR
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 22
container_issue 1
container_start_page 16
container_title Journal of cardiovascular electrophysiology
container_volume 22
creator AKOUM, NAZEM
DACCARETT, MARCOS
MCGANN, CHRIS
SEGERSON, NATHAN
VERGARA, GASTON
KUPPAHALLY, SUMAN
BADGER, TROY
BURGON, NATHAN
HASLAM, THOMAS
KHOLMOVSKI, EUGENE
MACLEOD, ROB
MARROUCHE, NASSIR
description MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation. Methods and Results: One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; 35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4. Conclusions: Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)
doi_str_mv 10.1111/j.1540-8167.2010.01876.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3133570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>843412829</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</originalsourceid><addsrcrecordid>eNqNkd9u0zAUxiMEYmPwCsh3XKUcx3-HBFIW2m5oYxMDjTvLSdzVJU2C7UL7BLw2zrJV4w7f2Drn-3728ZckCMMEx_V2NcGMQioxF5MMYhWwFHyyfZIc7htP4xkoS4kU5CB54f0KABMO7HlykIEEkQl8mPzJg7O6QTNbus5bj05N03t0bRpTBRSWBuV977o-ioJBVzpY0wak2xpdBxdLtztkW1ToqAzGobxsoqRrUbdAj8i2GcvvUI4-TtOLL2dovrG1qUe6rpYvk2cL3Xjz6n4_Sr7Npl-L0_T8cn5W5OdpxYTgaVkCFxoD50LUotYsoxmTEnQpaCaBGS4JYYJQwSnHrAagZU0wpxLKknBDjpIPI7fflGtTV3EapxsV51trt1OdturfTmuX6rb7pQgewBABb-4Brvu5MT6otfWViQO2ptt4JSmhOJPZcVTKUVnFn_XOLPa3YFBDjGqlhrTUkJYaYlR3MapttL5-_Mq98SG3KHg_Cn7bxuz-G6w-FdPhFP3p6Lc-mO3er90PxQURTN18nqtjWswuspPv6ob8BQqUumo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>843412829</pqid></control><display><type>article</type><title>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>AKOUM, NAZEM ; DACCARETT, MARCOS ; MCGANN, CHRIS ; SEGERSON, NATHAN ; VERGARA, GASTON ; KUPPAHALLY, SUMAN ; BADGER, TROY ; BURGON, NATHAN ; HASLAM, THOMAS ; KHOLMOVSKI, EUGENE ; MACLEOD, ROB ; MARROUCHE, NASSIR</creator><creatorcontrib>AKOUM, NAZEM ; DACCARETT, MARCOS ; MCGANN, CHRIS ; SEGERSON, NATHAN ; VERGARA, GASTON ; KUPPAHALLY, SUMAN ; BADGER, TROY ; BURGON, NATHAN ; HASLAM, THOMAS ; KHOLMOVSKI, EUGENE ; MACLEOD, ROB ; MARROUCHE, NASSIR</creatorcontrib><description>MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation. Methods and Results: One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; &lt;5%, mild or Utah stage 2; 5–20%, moderate or Utah stage 3; 20–35%, and extensive or Utah stage 4; &gt;35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4. Conclusions: Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)</description><identifier>ISSN: 1045-3873</identifier><identifier>EISSN: 1540-8167</identifier><identifier>DOI: 10.1111/j.1540-8167.2010.01876.x</identifier><identifier>PMID: 20807271</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>atrial fibrillation ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - epidemiology ; Atrial Fibrillation - surgery ; atrial remodeling ; catheter ablation ; Catheter Ablation - statistics &amp; numerical data ; Comorbidity ; Female ; Fibrosis - diagnosis ; Fibrosis - epidemiology ; Fibrosis - surgery ; Heart Atria - pathology ; Heart Atria - surgery ; Humans ; magnetic resonance imaging ; Magnetic Resonance Imaging - statistics &amp; numerical data ; Male ; Middle Aged ; Patient Selection ; Preoperative Care - statistics &amp; numerical data ; Prevalence ; Prognosis ; Risk Assessment ; Risk Factors ; Surgery, Computer-Assisted - statistics &amp; numerical data ; Utah - epidemiology</subject><ispartof>Journal of cardiovascular electrophysiology, 2011-01, Vol.22 (1), p.16-22</ispartof><rights>2010 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</citedby><cites>FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1540-8167.2010.01876.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1540-8167.2010.01876.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,781,785,886,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20807271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AKOUM, NAZEM</creatorcontrib><creatorcontrib>DACCARETT, MARCOS</creatorcontrib><creatorcontrib>MCGANN, CHRIS</creatorcontrib><creatorcontrib>SEGERSON, NATHAN</creatorcontrib><creatorcontrib>VERGARA, GASTON</creatorcontrib><creatorcontrib>KUPPAHALLY, SUMAN</creatorcontrib><creatorcontrib>BADGER, TROY</creatorcontrib><creatorcontrib>BURGON, NATHAN</creatorcontrib><creatorcontrib>HASLAM, THOMAS</creatorcontrib><creatorcontrib>KHOLMOVSKI, EUGENE</creatorcontrib><creatorcontrib>MACLEOD, ROB</creatorcontrib><creatorcontrib>MARROUCHE, NASSIR</creatorcontrib><title>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</title><title>Journal of cardiovascular electrophysiology</title><addtitle>J Cardiovasc Electrophysiol</addtitle><description>MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation. Methods and Results: One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; &lt;5%, mild or Utah stage 2; 5–20%, moderate or Utah stage 3; 20–35%, and extensive or Utah stage 4; &gt;35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4. Conclusions: Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)</description><subject>atrial fibrillation</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Atrial Fibrillation - surgery</subject><subject>atrial remodeling</subject><subject>catheter ablation</subject><subject>Catheter Ablation - statistics &amp; numerical data</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Fibrosis - diagnosis</subject><subject>Fibrosis - epidemiology</subject><subject>Fibrosis - surgery</subject><subject>Heart Atria - pathology</subject><subject>Heart Atria - surgery</subject><subject>Humans</subject><subject>magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Selection</subject><subject>Preoperative Care - statistics &amp; numerical data</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Surgery, Computer-Assisted - statistics &amp; numerical data</subject><subject>Utah - epidemiology</subject><issn>1045-3873</issn><issn>1540-8167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkd9u0zAUxiMEYmPwCsh3XKUcx3-HBFIW2m5oYxMDjTvLSdzVJU2C7UL7BLw2zrJV4w7f2Drn-3728ZckCMMEx_V2NcGMQioxF5MMYhWwFHyyfZIc7htP4xkoS4kU5CB54f0KABMO7HlykIEEkQl8mPzJg7O6QTNbus5bj05N03t0bRpTBRSWBuV977o-ioJBVzpY0wak2xpdBxdLtztkW1ToqAzGobxsoqRrUbdAj8i2GcvvUI4-TtOLL2dovrG1qUe6rpYvk2cL3Xjz6n4_Sr7Npl-L0_T8cn5W5OdpxYTgaVkCFxoD50LUotYsoxmTEnQpaCaBGS4JYYJQwSnHrAagZU0wpxLKknBDjpIPI7fflGtTV3EapxsV51trt1OdturfTmuX6rb7pQgewBABb-4Brvu5MT6otfWViQO2ptt4JSmhOJPZcVTKUVnFn_XOLPa3YFBDjGqlhrTUkJYaYlR3MapttL5-_Mq98SG3KHg_Cn7bxuz-G6w-FdPhFP3p6Lc-mO3er90PxQURTN18nqtjWswuspPv6ob8BQqUumo</recordid><startdate>201101</startdate><enddate>201101</enddate><creator>AKOUM, NAZEM</creator><creator>DACCARETT, MARCOS</creator><creator>MCGANN, CHRIS</creator><creator>SEGERSON, NATHAN</creator><creator>VERGARA, GASTON</creator><creator>KUPPAHALLY, SUMAN</creator><creator>BADGER, TROY</creator><creator>BURGON, NATHAN</creator><creator>HASLAM, THOMAS</creator><creator>KHOLMOVSKI, EUGENE</creator><creator>MACLEOD, ROB</creator><creator>MARROUCHE, NASSIR</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201101</creationdate><title>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</title><author>AKOUM, NAZEM ; DACCARETT, MARCOS ; MCGANN, CHRIS ; SEGERSON, NATHAN ; VERGARA, GASTON ; KUPPAHALLY, SUMAN ; BADGER, TROY ; BURGON, NATHAN ; HASLAM, THOMAS ; KHOLMOVSKI, EUGENE ; MACLEOD, ROB ; MARROUCHE, NASSIR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>atrial fibrillation</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Atrial Fibrillation - surgery</topic><topic>atrial remodeling</topic><topic>catheter ablation</topic><topic>Catheter Ablation - statistics &amp; numerical data</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Fibrosis - diagnosis</topic><topic>Fibrosis - epidemiology</topic><topic>Fibrosis - surgery</topic><topic>Heart Atria - pathology</topic><topic>Heart Atria - surgery</topic><topic>Humans</topic><topic>magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Selection</topic><topic>Preoperative Care - statistics &amp; numerical data</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Surgery, Computer-Assisted - statistics &amp; numerical data</topic><topic>Utah - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AKOUM, NAZEM</creatorcontrib><creatorcontrib>DACCARETT, MARCOS</creatorcontrib><creatorcontrib>MCGANN, CHRIS</creatorcontrib><creatorcontrib>SEGERSON, NATHAN</creatorcontrib><creatorcontrib>VERGARA, GASTON</creatorcontrib><creatorcontrib>KUPPAHALLY, SUMAN</creatorcontrib><creatorcontrib>BADGER, TROY</creatorcontrib><creatorcontrib>BURGON, NATHAN</creatorcontrib><creatorcontrib>HASLAM, THOMAS</creatorcontrib><creatorcontrib>KHOLMOVSKI, EUGENE</creatorcontrib><creatorcontrib>MACLEOD, ROB</creatorcontrib><creatorcontrib>MARROUCHE, NASSIR</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cardiovascular electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AKOUM, NAZEM</au><au>DACCARETT, MARCOS</au><au>MCGANN, CHRIS</au><au>SEGERSON, NATHAN</au><au>VERGARA, GASTON</au><au>KUPPAHALLY, SUMAN</au><au>BADGER, TROY</au><au>BURGON, NATHAN</au><au>HASLAM, THOMAS</au><au>KHOLMOVSKI, EUGENE</au><au>MACLEOD, ROB</au><au>MARROUCHE, NASSIR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</atitle><jtitle>Journal of cardiovascular electrophysiology</jtitle><addtitle>J Cardiovasc Electrophysiol</addtitle><date>2011-01</date><risdate>2011</risdate><volume>22</volume><issue>1</issue><spage>16</spage><epage>22</epage><pages>16-22</pages><issn>1045-3873</issn><eissn>1540-8167</eissn><abstract>MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation. Methods and Results: One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; &lt;5%, mild or Utah stage 2; 5–20%, moderate or Utah stage 3; 20–35%, and extensive or Utah stage 4; &gt;35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4. Conclusions: Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20807271</pmid><doi>10.1111/j.1540-8167.2010.01876.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1045-3873
ispartof Journal of cardiovascular electrophysiology, 2011-01, Vol.22 (1), p.16-22
issn 1045-3873
1540-8167
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3133570
source MEDLINE; Access via Wiley Online Library
subjects atrial fibrillation
Atrial Fibrillation - diagnosis
Atrial Fibrillation - epidemiology
Atrial Fibrillation - surgery
atrial remodeling
catheter ablation
Catheter Ablation - statistics & numerical data
Comorbidity
Female
Fibrosis - diagnosis
Fibrosis - epidemiology
Fibrosis - surgery
Heart Atria - pathology
Heart Atria - surgery
Humans
magnetic resonance imaging
Magnetic Resonance Imaging - statistics & numerical data
Male
Middle Aged
Patient Selection
Preoperative Care - statistics & numerical data
Prevalence
Prognosis
Risk Assessment
Risk Factors
Surgery, Computer-Assisted - statistics & numerical data
Utah - epidemiology
title Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T06%3A32%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atrial%20Fibrosis%20Helps%20Select%20the%20Appropriate%20Patient%20and%20Strategy%20in%20Catheter%20Ablation%20of%20Atrial%20Fibrillation:%20A%20DE-MRI%20Guided%20Approach&rft.jtitle=Journal%20of%20cardiovascular%20electrophysiology&rft.au=AKOUM,%20NAZEM&rft.date=2011-01&rft.volume=22&rft.issue=1&rft.spage=16&rft.epage=22&rft.pages=16-22&rft.issn=1045-3873&rft.eissn=1540-8167&rft_id=info:doi/10.1111/j.1540-8167.2010.01876.x&rft_dat=%3Cproquest_pubme%3E843412829%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=843412829&rft_id=info:pmid/20807271&rfr_iscdi=true